Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
myHMB Clear is a nutritional supplement ingredient developed by Metabolic Technologies, LLC, featuring the free acid form of beta-hydroxy beta-methylbutyrate (HMB). HMB is a naturally occurring metabolite of the essential amino acid leucine. Unlike the traditional calcium salt form, the free acid formulation is designed for faster absorption and higher peak plasma levels. It supports muscle health and athletic performance through a dual mechanism: activating the mTOR (mechanistic target of rapamycin) pathway to stimulate muscle protein synthesis and inhibiting the ubiquitin-proteasome proteolytic pathway to reduce muscle protein breakdown. It is marketed to enhance strength gains, lean body mass, and recovery from intense training.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on myHMB Clear.